The Pharmaceuticals Pricing Board (Hila) publishes a list of medicinal products subject to the price notification procedure 4 times a year. The price notification procedure concerns products included in generic substitution and the reference price system as well as products undergoing a so-called transition period.
A price notification must be submitted for any product subject to the price notification procedure to Kela at the latest 21 days before the first day of each quarter. If the product is subject to the price notification procedure under the reference price system and no notification is made about the product, the product becomes non-reimbursable at the beginning of the quarter.
On the basis of the prices notified, Kela determines the price bands. In addition, Kela forwards the price notifications to Hila for determination of the reference prices.
Read more on Hila's website